Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Mammalian Cell Fermentation Technology Market In 2029?
The market size of mammalian cell fermentation technology has witnessed a swift expansion in the last few years. It is projected to surge from $51.29 billion in 2024 to $57.37 billion in 2025, growing at a compound annual growth rate (CAGR) of 11.9%. The substantial growth during the historical period can be credited to a rise in demand for biologics and biosimilars, enhanced focus on personalized medicine, an increase in the production of biopharmaceuticals, and a surge in demand for scalable and efficient cell culture techniques.
In the coming years, the market size for mammalian cell fermentation technology is projected to significantly expand, reaching an estimated $87.07 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 11.0%. The expected growth during the forecast period is largely due to the increasing incidence of chronic diseases, amplified investments from multinational corporations, heightened occurrence of chronic conditions, greater adoption of innovative bioprocessing techniques, growing investment towards the research and development of new recombinant proteins and the escalating demand for cancer treatments. Noteworthy trends in the forecast period include technological progress in cell culture, advances in bioreactor design, evolution of next-generation bioprocessing technologies, incorporation of multi-omics approaches, and the move towards technology-powered automation.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Mammalian Cell Fermentation Technology Market?
The burgeoning need for biologics is predicted to catalyze the expansion of the mammalian cell fermentation technology market. Biologics, which are medicinal substances extracted from living beings or their parts, are frequently employed in curing ailments like cancer, autoimmune disorders, and contagious diseases. The escalated demand for biologics is fueled by progress in biotechnology, their effectiveness in managing widespread chronic diseases like cancer and autoimmune disorders, regulatory sanctions, and amplified investment in research and discovery. Mammalian cell fermentation technology is proficient in generating intricate biologics that cater to the expanding requirement for personalized and targeted treatment methodologies. Factors like its scalability, versatility, and ability to manufacture superior proteins, promote innovation in the biopharmaceutical sector. For example, the National Library of Medicine, a US-based medical library, reported in February 2024 that in 2023, the FDA approved 55 novel drugs, encompassing 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This marked a 50% rise in comparison to the 37 approvals in 2022. Hence, the escalated demand for biologics is propelling the growth of the bacterial cell fermentation technology market.
Which Key Market Segments Comprise the Mammalian Cell Fermentation Technology Market and Drive Its Revenue Growth?
The mammalian cell fermentation technologymarket covered in this report is segmented –
1) By Type: Chinese Hamster Ovary Cell Fermentation; Human Embryonic Kidney Cell Fermentation; Baby Hamster Kidney Cell Fermentation; Murine Myeloma Cell Fermentation; Other Types
2) By Application: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Hormones; Enzymes; Other Applications
3) By End-Use: Biopharmaceutical Companies; Contract Research Organizations And Contract Development and Manufacturing Organizations; Academic And Research Institutes
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=16473&type=smp
Which Areas Are Leading Regions in the Mammalian Cell Fermentation Technology Market Expansion Across the Globe?
North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theMammalian Cell Fermentation Technology Market Over the Coming Years?
Leading businesses in the mammalian cell fermentation technology market are enhancing their market standing by innovating and advancing technologies like mammalian cell culture. This technology is vital across several sectors, including biomanufacturing, research, and regenerative medicine, due to its use in creating therapeutic proteins, vaccines, and functional cell or tissue substitutes. An example of this is when Syntegon, a biotech firm based in Germany, introduced its new Modular Bioprocessing Platform (MBP) at Achema 2024 in June 2024. The new platform is developed to address significant obstacles in biopharmaceutical manufacturing. It provides a highly adaptable, fully comprehensive, and automatic solution appropriate for diverse applications like microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The MBP’s modular structure reduces lead times and costs while sustaining high functionality and quality, living up to the “made in Germany” reputation. Its readymade cleanroom layout accommodates all ancillary technology outside the cleanroom, making operations more efficient and maintenance easier.
View the full report here:
How Is the Mammalian Cell Fermentation Technology Market Conceptually Defined?
Mammalian cell fermentation technology refers to the process of cultivating mammalian cells under controlled conditions to produce biopharmaceuticals, vaccines, or other biological products. This technology involves optimizing cell growth and protein expression in bioreactors or fermenters, ensuring the production of high-quality and consistent yields of desired therapeutic proteins or substances.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16473
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model